Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, Baltimore, Maryland, USA.
Trials. 2010 Nov 19;11:112. doi: 10.1186/1745-6215-11-112.
Sharing of final research data from clinical research is an essential part of the scientific method. The U.S. National Institutes of Health require some grant applications to include plans for sharing final research data, which it defines as the factual materials necessary to document, support, and validate research findings. In the U.S., however, the Privacy Rule adopted under the Health Insurance Portability and Accountability Act impedes the sharing of final research data. In most situations, final research data may be shared only where all information that could possibly be used to identify the subject has been deleted, or where the subject has given authorization for specific research, or an Institutional Review Board has granted a waiver.
分享临床研究的最终研究数据是科学方法的重要组成部分。美国国立卫生研究院要求部分资助申请包含分享最终研究数据的计划,它将最终研究数据定义为记录、支持和验证研究结果所需的事实材料。然而,在美国,《健康保险携带和责任法案》下通过的《隐私规则》阻碍了最终研究数据的共享。在大多数情况下,只有在已删除所有可能用于识别对象的信息的情况下,或者在对象已经授权进行特定研究的情况下,或者机构审查委员会授予豁免的情况下,才能共享最终研究数据。